Angela Harmantas is a senior financial journalist with Proactive Investors. She has nearly ten years' experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. She currently resides in Toronto.
The new antibody discovery collaboration with Entos Pharmaceuticals will use ImmunoPrecise's B cell Select platform in developing a therapeutic candidate to fight cancer
LexaGene is a biotechnology company that is pioneering the first fully-automated pathogen detection platform for use in diagnostics and sample analysis.
The agreement allows the Namaste MD application to act as a direct-connect platform to enable patients to immediately transition from clinical consultation to connect with a medical professional
HC Wainwright & Co set a price target of US$6, while Aegis Capital put it at US$3 on the pharmaceutical company
Chris Avery has launched numerous glucose monitoring devices, stents and insulin pumps into the UK and European markets
The company entered into a joint-venture agreement with three-time world heavyweight championship Lewis to develop and commercialize a new line of branded nutritional supplements for men
The company is focused on the acquisition and development of novel treatments targeting unmet needs in infectious disease
Sirona’s shares have been on a tear over the past few months, rising over 640% since the beginning of the year